Plant ID: NPO17807
Plant Latin Name: Dysosma versipellis
Taxonomy Genus: Dysosma
Taxonomy Family: Berberidaceae
NCBI TaxonomyDB:
93611
Plant-of-the-World-Online:
107257-1
China
NPSR1; | |
PPARA; PPARD; | |
ELANE; | |
TLR2; | |
MAPT; HTT; FABP3; LMNA; FABP2; FABP4; FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 1.900E-08 | 1.034E-04 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.942E-08 | 1.280E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 3.222E-07 | 6.852E-04 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 3.461E-07 | 6.852E-04 | CYP2C19, CYP2C9, CYP3A4, NPC1, NR0B1, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 6.656E-07 | 1.115E-03 | NR0B1, NR3C1, PPARA, PPARD |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 7.151E-06 | 6.253E-03 | HIF1A, MAPT, NR3C1 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 8.126E-06 | 6.253E-03 | CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 8.614E-06 | 6.253E-03 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 1.152E-05 | 7.836E-03 | HIF1A, LMNA, PPARA, PPARD, TLR2 |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 1.571E-05 | 9.500E-03 | NR0B1, NR3C1, PPARA, PPARD |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.025E-05 | 1.161E-02 | CYP2C19, CYP2C9, CYP3A4 |
CC | GO:0044464; cell part | GO:0005737; cytoplasm | 4.961E-05 | 1.959E-02 | CYP3A4, ELANE, FABP3, FABP4, FABP5, HIF1A, HTT, MAPT, NPSR1, NR0B1, NR3C1, SMN1, SMN2, TLR2 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 8.887E-05 | 2.481E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 1.049E-04 | 2.753E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 2.051E-04 | 4.379E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.301E-10 | 7.677E-09 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.760E-06 | 1.404E-04 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 6.624E-05 | 1.303E-03 | CYP2C9, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.109E-04 | 1.635E-03 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.294E-03 | 2.476E-02 | CYP2C9, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.518E-03 | 2.476E-02 | CYP2C9, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.164E-03 | 2.666E-02 | CYP2C9, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 1.024E-02 | 6.240E-02 | PAX8, HIF1A, PPARD |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 7.282E-03 | 5.371E-02 | CYP2C9, CYP2C19 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 1.058E-02 | 6.240E-02 | RAB9A, TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|